Large animal models for cardiac stem cell therapies

Theriogenology

Volumn 75, Issue 8, 2011, Pages 1416-1425

  Gandolfi, F ^a   Vanelli, A ^a   Pennarossa, G ^a   Rahaman, M ^a   Acocella, F ^a   Brevini, T A L ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Animal model; Dog; Heart; Pig; Sheep

Indexed keywords

ANIMALIA; CANIS FAMILIARIS; MUS; OVIS ARIES; SUIDAE;

EID: 79953288778     PISSN: 0093691X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.theriogenology.2011.01.026     Document Type: Review

References (90)

1. Lopez A.D., Mathers C.D., Ezzati M., Jamison D.T., Murray C.J. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006, 367:1747-1757.
2. Gaziano T.A., Bitton A., Anand S., Abrahams-Gessel S., Murphy A. Growing epidemic of coronary heart disease in low- and middle-income countries. Curr Probl Cardiol 2010, 35:72-115.
3. Segers V.F., Lee R.T. Stem-cell therapy for cardiac disease. Nature 2008, 451:937-942.
4. Dixon J.A., Spinale F.G. Large animal models of heart failure: a critical link in the translation of basic science to clinical practice. Circ Heart Fail 2009, 2:262-271.
5. Blankesteijn W.M., Creemers E., Lutgens E., Cleutjens J.P., Daemen M.J., Smits J.F. Dynamics of cardiac wound healing following myocardial infarction: observations in genetically altered mice. Acta Physiol Scand 2001, 173:75-82.
6. Rakusan K., Nagai J. Morphometry of arterioles and capillaries in hearts of senescent mice. Cardiovasc Res 1994, 28:969-972.
7. Stoker M.E., Gerdes A.M., May J.F. Regional differences in capillary density and myocyte size in the normal human heart. Anat Rec 1982, 202:187-191.
8. Doevendans P.A., Daemen M.J., de Muinck E.D., Smits J.F. Cardiovascular phenotyping in mice. Cardiovasc Res 1998, 39:34-49.
9. Swynghedauw B. Developmental and functional adaptation of contractile proteins in cardiac and skeletal muscles. Physiol Rev 1986, 66:710-771.
10. Liu W., Ashford M.W., Chen J., Watkins M.P., Williams T.A., Wickline S.A., Yu X. MR tagging demonstrates quantitative differences in regional ventricular wall motion in mice, rats, and men. Am J Physiol Heart Circ Physiol 2006, 291:H2515-H2521.
11. Reimer K.A., Jennings R.B. The "wavefront phenomenon" of myocardial ischemic cell death. II. Transmural progression of necrosis within the framework of ischemic bed size (myocardium at risk) and collateral flow. Lab Invest 1979, 40:633-644.
12. Jugdutt B.I., Menon V. Valsartan-induced cardioprotection involves angiotensin II type 2 receptor upregulation in dog and rat models of in vivo reperfused myocardial infarction. J Card Fail 2004, 10:74-82.
13. White F.C., Roth D.M., Bloor C.M. The pig as a model for myocardial ischemia and exercise. Lab Anim Sci 1986, 36:351-356.
14. Mukherjee R., Brinsa T.A., Dowdy K.B., Scott A.A., Baskin J.M., Deschamps A.M., Lowry A.S., Escobar G.P., Lucas D.G., Yarbrough W.M., Zile M.R., Spinale F.G. Myocardial infarct expansion and matrix metalloproteinase inhibition. Circulation 2003, 107:618-625.
15. Weaver M.E., Pantely G.A., Bristow J.D., Ladley H.D. A quantitative study of the anatomy and distribution of coronary arteries in swine in comparison with other animals and man. Cardiovasc Res 1986, 20:907-917.
16. Bertho E., Gagnon G. A Comparative Study in Three Dimension of the Blood Supply of the Normal Interventricular Septum in Human, Canine, Bovine, Procine, Ovine and Equine Heart. Dis Chest 1964, 46:251-262.
17. Lu H., Xu X., Zhang M., Cao R., Brakenhielm E., Li C., Lin H., Yao G., Sun H., Qi L., Tang M., Dai H., Zhang Y., Su R., Bi Y., Cao Y. Combinatorial protein therapy of angiogenic and arteriogenic factors remarkably improves collaterogenesis and cardiac function in pigs. Proc Natl Acad Sci USA 2007, 104:12140-12145.
18. Myocardial infarct expansion and matrix metalloproteinase inhibition. Circulation 2003, 107:618-625.
19. Gorman J.H., Gorman R.C., Plappert T., Jackson B.M., Hiramatsu Y., St John-Sutton M.G., Edmunds L.H. Infarct size and location determine development of mitral regurgitation in the sheep model. J Thorac Cardiovasc Surg 1998, 115:615-622.
20. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., Moorman M.A., Simonetti D.W., Craig S., Marshak D.R. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147.
21. Silva G.V., Litovsky S., Assad J.A., Sousa A.L., Martin B.J., Vela D., Coulter S.C., Lin J., Ober J., Vaughn W.K., Branco R.V., Oliveira E.M., He R., Geng Y.J., Willerson J.T., Perin E.C. Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model. Circulation 2005, 111:150-156.
22. Rose R.A., Keating A., Backx P.H. Do mesenchymal stromal cells transdifferentiate into functional cardiomyocytes?. Circ Res 2008, 103:e120.
23. Gnecchi M., Zhang Z., Ni A., Dzau V.J. Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res 2008, 103:1204-1219.
24. Aggarwal S., Pittenger M.F. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005, 105:1815-1822.
25. Boudoulas K.D., Hatzopoulos A.K. Cardiac repair and regeneration: the Rubik's cube of cell therapy for heart disease. Dis Model Mech 2009, 2:344-358.
26. Buckingham M., Montarras D. Skeletal muscle stem cells. Curr Opin Genet Dev 2008, 18:330-336.
27. Reinecke H., Poppa V., Murry C.E. Skeletal muscle stem cells do not transdifferentiate into cardiomyocytes after cardiac grafting. J Mol Cell Cardiol 2002, 34:241-249.
28. Leobon B., Garcin I., Menasche P., Vilquin J.T., Audinat E., Charpak S. Myoblasts transplanted into rat infarcted myocardium are functionally isolated from their host. Proc Natl Acad Sci USA 2003, 100:7808-7811.
29. Martin-Rendon E., Brunskill S.J., Hyde C.J., Stanworth S.J., Mathur A., Watt S.M. Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review. Eur Heart J 2008, 29:1807-1818.
30. Hosoda T., Kajstura J., Leri A., Anversa P. Mechanisms of myocardial regeneration. Circ J 2010, 74:13-17.
31. Passier R., van Laake L.W., Mummery C.L. Stem-cell-based therapy and lessons from the heart. Nature 2008, 453:322-329.
32. Narazaki G., Uosaki H., Teranishi M., Okita K., Kim B., Matsuoka S., Yamanaka S., Yamashita J.K. Directed and systematic differentiation of cardiovascular cells from mouse induced pluripotent stem cells. Circulation 2008, 118:498-506.
33. Laflamme M.A., Chen K.Y., Naumova A.V., Muskheli V., Fugate J.A., Dupras S.K., Reinecke H., Xu C., Hassanipour M., Police S., O'Sullivan C., Collins L., Chen Y., Minami E., Gill E.A., Ueno S., Yuan C., Gold J., Murry C.E. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotech 2007, 25:1015.
34. Yan P., Nagasawa A., Uosaki H., Sugimoto A., Yamamizu K., Teranishi M., Matsuda H., Matsuoka S., Ikeda T., Komeda M., Sakata R., Yamashita J.K. Cyclosporin-A potently induces highly cardiogenic progenitors from embryonic stem cells. Biochem Biophys Res Commun 2009, 379:115-120.
35. Nussbaum J. Transplantation of undifferentiated murine embryonic stem cells in the heart: teratoma formation and immune response. FASEB J 2007, 21:1345.
36. Behfar A., Faustino R.S., Arrell D.K., Dzeja P.P., Perez-Terzic C., Terzic A. Guided stem cell cardiopoiesis: discovery and translation. J Mol Cell Cardiol 2008, 45:523-529.
37. Laflamme M.A., Zbinden S., Epstein S.E., Murry C.E. Cell-based cardiac repair: pathophysiologic mechanisms. Annu Rev Pathol Mech Dis 2007, 2:307.
38. Ieda M., Fu J.-D., Delgado-Olguin P., Vedantham V., Hayashi Y., Bruneau B.G., Srivastava D. Direct Reprogramming of Fibroblasts into Functional Cardiomyocytes by Defined Factors. Cell 2010, 142:375-386.
39. Torella D., Ellison G.M., Karakikes I., Nadal-Ginard B. Growth-factor-mediated cardiac stem cell activation in myocardial regeneration. Nat Clin Pract Cardiovasc Med 2007, 4(Suppl 1):S46-S51.
40. Ausoni S., Sartore S. From fish to amphibians to mammals: in search of novel strategies to optimize cardiac regeneration. The Journal of Cell Biology 2009, 184:357-364.
41. Bouchet-Marquis C., Dubochet J., Fakan S. Cryoelectron microscopy of vitrified sections: a new challenge for the analysis of functional nuclear architecture. Histochem Cell Biol 2006, 125:43-51.
42. Mouquet F., Pfister O., Jain M., Oikonomopoulos A., Ngoy S., Summer R., Fine A., Liao R. Restoration of cardiac progenitor cells after myocardial infarction by self-proliferation and selective homing of bone marrow-derived stem cells. Circ Res 2005, 97:1090-1092.
43. Beltrami A.P., Barlucchi L., Torella D., Baker M., Limana F., Chimenti S., Kasahara H., Rota M., Musso E., Urbanek K., Leri A., Kajstura J., Nadal-Ginard B., Anversa P. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 2003, 114:763-776.
44. Rota M., Padin-Iruegas M.E., Misao Y., De Angelis A., Maestroni S., Ferreira-Martins J., Fiumana E., Rastaldo R., Arcarese M.L., Mitchell T.S., Boni A., Bolli R., Urbanek K., Hosoda T., Anversa P., Leri A., Kajstura J. Local activation or implantation of cardiac progenitor cells rescues scarred infarcted myocardium improving cardiac function. Circ Res 2008, 103:107-116.
45. Laugwitz K.L., Moretti A., Caron L., Nakano A., Chien K.R. Islet1 cardiovascular progenitors: a single source for heart lineages?. Development 2008, 135:193-205.
46. Smith R.R., Barile L., Cho H.C., Leppo M.K., Hare J.M., Messina E., Giacomello A., Abraham M.R., Marban E. Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. Circulation 2007, 115:896-908.
47. Zeisberg E.M., Tarnavski O., Zeisberg M., Dorfman A.L., McMullen J.R., Gustafsson E., Chandraker A., Yuan X., Pu W.T., Roberts A.B., Neilson E.G., Sayegh M.H., Izumo S., Kalluri R. Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat Med 2007, 13:952-961.
48. van Tuyn J., Atsma D.E., Winter E.M., van der Velde-van Dijke I., Pijnappels D.A., Bax N.A., Knaan-Shanzer S., Gittenberger-de Groot A.C., Poelmann R.E., van der Laarse A., van der Wall E.E., Schalij M.J., de Vries A.A. Epicardial cells of human adults can undergo an epithelial-to-mesenchymal transition and obtain characteristics of smooth muscle cells in vitro. Stem Cells 2007, 25:271-278.
49. Taylor D.A., Atkins B.Z., Hungspreugs P., Jones T.R., Reedy M.C., Hutcheson K.A., Glower D.D., Kraus W.E. Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat Med 1998, 4:929-933.
50. Taylor D.A., Silvestry S.C., Bishop S.P., Annex B.H., Lilly R.E., Glower D.D., Kraus W.E. Delivery of primary autologous skeletal myoblasts into rabbit heart by coronary infusion: a potential approach to myocardial repair. Proc Assoc Am Physicians 1997, 109:245-253.
51. Garbade J., Dhein S., Lipinski C., Aupperle H., Arsalan M., Borger M.A., Barten M.J., Lehmann S., Walther T., Mohr F.-W. Bone Marrow-Derived Stem Cells Attenuate Impaired Contractility and Enhance Capillary Density in a Rabbit Model of Doxorubicin-Induced Failing Hearts. J Card Surg 2009, 24:591-599.
52. Jin B., Luo X.P., Ni H.C., Li Y., Shi H.M. Cardiac matrix remodeling following intracoronary cell transplantation in dilated cardiomyopathic rabbits. Mol Biol Rep 2010, 37:3037-3042.
53. Xu Y.-L., Gao Y.-H., Liu Z., Tan K.-B., Hua X., Fang Z.-Q., Wang Y.-L., Wang Y.-J., Xia H.-M., Zhuo Z.-X. Myocardium-targeted transplantation of mesenchymal stem cells by diagnostic ultrasound-mediated microbubble destruction improves cardiac function in myocardial infarction of New Zealand rabbits. Int J Cardiol 2010, 138:182-195.
54. Yoon P.D., Kao R.L., Magovern G.J. Myocardial regeneration. Transplanting satellite cells into damaged myocardium. Tex Heart Inst J 1995, 22:119-125.
55. Chiu R.C., Zibaitis A., Kao R.L. Cellular cardiomyoplasty: myocardial regeneration with satellite cell implantation. Ann Thorac Surg 1995, 60:12-18.
56. Bartunek J., Croissant J.D., Wijns W., Gofflot S., de Lavareille A., Vanderheyden M., Kaluzhny Y., Mazouz N., Willemsen P., Penicka M., Mathieu M., Homsy C., De Bruyne B., McEntee K., Lee I.W., Heyndrickx G.R. Pretreatment of adult bone marrow mesenchymal stem cells with cardiomyogenic growth factors and repair of the chronically infarcted myocardium. Am J Physiol Heart Circ Physiol 2007, 292:H1095-H1104.
57. Vulliet P.R., Greeley M., Halloran S.M., MacDonald K.A., Kittleson M.D. Intra-coronary arterial injection of mesenchymal stromal cells and microinfarction in dogs. Lancet 2004, 363:783-784.
58. Mitchell A.J., Sabondjian E., Sykes J., Deans L., Zhu W., Lu X., Feng Q., Prato F.S., Wisenberg G. Comparison of initial cell retention and clearance kinetics after subendocardial or subepicardial injections of endothelial progenitor cells in a canine myocardial infarction model. J Nucl Med 2010, 51:413-417.
59. Linke A., Muller P., Nurzynska D., Casarsa C., Torella D., Nascimbene A., Castaldo C., Cascapera S., Bohm M., Quaini F., Urbanek K., Leri A., Hintze T.H., Kajstura J., Anversa P. Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function. Proc Natl Acad Sci USA 2005, 102:8966-8971.
60. Bartosh T.J., Wang Z., Rosales A.A., Dimitrijevich S.D., Roque R.S. 3D-model of adult cardiac stem cells promotes cardiac differentiation and resistance to oxidative stress. J Cell Biochem 2008, 105:612-623.
61. Weir, Morel-Kopp M.C., Gill A., Tinworth K., Ladd L., Hunyor S.N., Ward C. Mesenchymal stem cells: isolation, characterisation and in vivo fluorescent dye tracking. Heart Lung Circ 2008, 17:395-403.
62. Hamamoto H., Gorman J.H., Ryan L.P., Hinmon R., Martens T.P., Schuster M.D., Plappert T., Kiupel M., St John-Sutton M.G., Itescu S., Gorman R.C. Allogeneic mesenchymal precursor cell therapy to limit remodeling after myocardial infarction: the effect of cell dosage. Ann Thorac Surg 2009, 87:794-801.
63. Kalfa D., Bel A., Chen-Tournoux A., Della Martina A., Rochereau P., Coz C., Bellamy V., Bensalah M., Vanneaux V., Lecourt S., Mousseaux E., Bruneval P., Larghero J., Menasche P. A polydioxanone electrospun valved patch to replace the right ventricular outflow tract in a growing lamb model. Biomaterials 2010, 31:4056-4063.
64. Sutherland F.W., Perry T.E., Yu Y., Sherwood M.C., Rabkin E., Masuda Y., Garcia G.A., McLellan D.L., Engelmayr G.C., Sacks M.S., Schoen F.J., Mayer J.E. From stem cells to viable autologous semilunar heart valve. Circulation 2005, 111:2783-2791.
65. Vincentelli A., Wautot F., Juthier F., Fouquet O., Corseaux D., Marechaux S., Le Tourneau T., Fabre O., Susen S., Van Belle E., Mouquet F., Decoene C., Prat A., Jude B. In vivo autologous recellularization of a tissue-engineered heart valve: are bone marrow mesenchymal stem cells the best candidates?. J Thorac Cardiovasc Surg 2007, 134:424-432.
66. Sales V.L., Mettler B.A., Engelmayr G.C., Aikawa E., Bischoff J., Martin D.P., Exarhopoulos A., Moses M.A., Schoen F.J., Sacks M.S., Mayer J.E. Endothelial progenitor cells as a sole source for ex vivo seeding of tissue-engineered heart valves. Tissue Eng Part A 2010, 16:257-267.
67. Ghostine S., Carrion C., Souza L.C., Richard P., Bruneval P., Vilquin J.T., Pouzet B., Schwartz K., Menasche P., Hagege A.A. Long-term efficacy of myoblast transplantation on regional structure and function after myocardial infarction. Circulation 2002, 106:I131-I136.
68. Kamihata H., Matsubara H., Nishiue T., Fujiyama S., Tsutsumi Y., Ozono R., Masaki H., Mori Y., Iba O., Tateishi E., Kosaki A., Shintani S., Murohara T., Imaizumi T., Iwasaka T. Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines. Circulation 2001, 104:1046-1052.
69. Bhakta S., Greco N.J., Finney M.R., Scheid P.E., Hoffman R.D., Joseph M.E., Banks J.J., Laughlin M.J., Pompili V.J. The safety of autologous intracoronary stem cell injections in a porcine model of chronic myocardial ischemia. J Invasive Cardiol 2006, 18:212-218.
70. Makela J., Ylitalo K., Lehtonen S., Dahlbacka S., Niemela E., Kiviluoma K., Rimpilainen J., Alaoja H., Paavonen T., Lehenkari P., Juvonen T., Anttila V. Bone marrow-derived mononuclear cell transplantation improves myocardial recovery by enhancing cellular recruitment and differentiation at the infarction site. J Thorac Cardiovasc Surg 2007, 134:565-573.
71. Kamihata H., Matsubara H., Nishiue T., Fujiyama S., Amano K., Iba O., Imada T., Iwasaka T. Improvement of collateral perfusion and regional function by implantation of peripheral blood mononuclear cells into ischemic hibernating myocardium. Arterioscler Thromb Vasc Biol 2002, 22:1804-1810.
72. Doyle B., Sorajja P., Hynes B., Kumar A.H., Araoz P.A., Stalboerger P.G., Miller D., Reed C., Schmeckpeper J., Wang S., Liu C., Terzic A., Kruger D., Riederer S., Caplice N.M. Progenitor cell therapy in a porcine acute myocardial infarction model induces cardiac hypertrophy, mediated by paracrine secretion of cardiotrophic factors including TGFbeta1. Stem Cells Dev 2008, 17:941-951.
73. Pak H.N., Qayyum M., Kim D.T., Hamabe A., Miyauchi Y., Lill M.C., Frantzen M., Takizawa K., Chen L.S., Fishbein M.C., Sharifi B.G., Chen P.S., Makkar R. Mesenchymal stem cell injection induces cardiac nerve sprouting and increased tenascin expression in a Swine model of myocardial infarction. J Cardiovasc Electrophysiol 2003, 14:841-848.
74. Kraitchman D.L., Heldman A.W., Atalar E., Amado L.C., Martin B.J., Pittenger M.F., Hare J.M., Bulte J.W. In vivo magnetic resonance imaging of mesenchymal stem cells in myocardial infarction. Circulation 2003, 107:2290-2293.
75. He G., Zhang H., Wei H., Wang Y., Zhang X., Tang Y., Wei Y., Hu S. In vivo imaging of bone marrow mesenchymal stem cells transplanted into myocardium using magnetic resonance imaging: a novel method to trace the transplanted cells. Int J Cardiol 2007, 114:4-10.
76. Liu J., Hu Q., Wang Z., Xu C., Wang X., Gong G., Mansoor A., Lee J., Hou M., Zeng L., Zhang J.R., Jerosch-Herold M., Guo T., Bache R.J., Zhang J. Autologous stem cell transplantation for myocardial repair. Am J Physiol Heart Circ Physiol 2004, 287:H501-H511.
77. Amado L.C., Saliaris A.P., Schuleri K.H., St John M., Xie J.S., Cattaneo S., Durand D.J., Fitton T., Kuang J.Q., Stewart G., Lehrke S., Baumgartner W.W., Martin B.J., Heldman A.W., Hare J.M. Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc Natl Acad Sci USA 2005, 102:11474-11479.
78. Poh K.K., Sperry E., Young R.G., Freyman T., Barringhaus K.G., Thompson C.A. Repeated direct endomyocardial transplantation of allogeneic mesenchymal stem cells: safety of a high dose, "off-the-shelf", cellular cardiomyoplasty strategy. Int J Cardiol 2007, 117:360-364.
79. Makkar R.R., Price M.J., Lill M., Frantzen M., Takizawa K., Kleisli T., Zheng J., Kar S., McClelan R., Miyamota T., Bick-Forrester J., Fishbein M.C., Shah P.K., Forrester J.S., Sharifi B., Chen P.S., Qayyum M. Intramyocardial injection of allogenic bone marrow-derived mesenchymal stem cells without immunosuppression preserves cardiac function in a porcine model of myocardial infarction. J Cardiovasc Pharmacol Ther 2005, 10:225-233.
80. Schuleri K.H., Feigenbaum G.S., Centola M., Weiss E.S., Zimmet J.M., Turney J., Kellner J., Zviman M.M., Hatzistergos K.E., Detrick B., Conte J.V., McNiece I., Steenbergen C., Lardo A.C., Hare J.M. Autologous mesenchymal stem cells produce reverse remodelling in chronic ischaemic cardiomyopathy. Eur Heart J 2009, 30:2722-2732.
81. Valina C., Pinkernell K., Song Y.H., Bai X., Sadat S., Campeau R.J., Le Jemtel T.H., Alt E. Intracoronary administration of autologous adipose tissue-derived stem cells improves left ventricular function, perfusion, and remodelling after acute myocardial infarction. Eur Heart J 2007, 28:2667-2677.
82. Sartore S., Lenzi M., Angelini A., Chiavegato A., Gasparotto L., De Coppi P., Bianco R., Gerosa G. Amniotic mesenchymal cells autotransplanted in a porcine model of cardiac ischemia do not differentiate to cardiogenic phenotypes. Eur J Cardiothorac Surg 2005, 28:677-684.
83. Galvez B.G., Sampaolesi M., Barbuti A., Crespi A., Covarello D., Brunelli S., Dellavalle A., Crippa S., Balconi G., Cuccovillo I., Molla F., Staszewsky L., Latini R., Difrancesco D., Cossu G. Cardiac mesoangioblasts are committed, self-renewable progenitors, associated with small vessels of juvenile mouse ventricle. Cell Death Differ 2008, 15:1417-1428.
84. Barbuti A., Galvez B.G., Crespi A., Scavone A., Baruscotti M., Brioschi C., Cossu G., DiFrancesco D. Mesoangioblasts from ventricular vessels can differentiate in vitro into cardiac myocytes with sinoatrial-like properties. J Mol Cell Cardiol 2010, 48:415-423.
85. Galvez B.G., Covarello D., Tolorenzi R., Brunelli S., Dellavalle A., Crippa S., Mohammed S.A., Scialla L., Cuccovillo I., Molla F., Staszewsky L., Maisano F., Sampaolesi M., Latini R., Cossu G. Human cardiac mesoangioblasts isolated from hypertrophic cardiomyopathies are greatly reduced in proliferation and differentiation potency. Cardiovasc Res 2009, 83:707-716.
86. Pendyala L., Goodchild T., Gadesam R.R., Chen J., Robinson K., Chronos N., Hou D. Cellular Cardiomyoplasty and Cardiac Regeneration. Curr Cardiol Rev 2008, 4:72-80.
87. Aicher A., Brenner W., Zuhayra M., et al. Assessment of the tissue distribution of transplanted human endothelial progenitor cells by radioactive labeling. Circulation 2003, 107:2134-2139.
88. Vulliet P.R., Greeley M., Halloran S.M., et al. Intracoronary arterial injection of mesenchymal stromal cells and microinfarction in dogs. Lancet 2004, 363:783-784.
89. Wu Z., Chen J., Ren J., Bao L., Liao J., Cui C., Rao L., Li H., Gu Y., Dai H., Zhu H., Teng X., Cheng L., Xiao L. Generation of pig induced pluripotent stem cells with a drug-inducible system. J Mol Cell Biol 2009, 1:46-54.
90. Roberts R.M., Telugu B.P., Ezashi T. Induced pluripotent stem cells from swine (Sus scrofa): why they may prove to be important. Cell Cycle 2009, 8:3078-3081.